In summary, our findings revealed five significant genes: CP, STEAP3, SAT1, TFRC, and LPCAT3. Among them, CP and STEAP3 might be used as highly correlated biomarkers of AF and HF, providing new insights into their common pathogenesis and offering therapeutic targets for patients with coexisting AF and HF. This evidence concerns the gene SAT1 and atrial fibrillation.